
CEO Mark Foster jams with Chris & Mike D. as they discuss how CurvaFix addresses the challenges of complex pelvic fractures, especially those fragility fractures that go untreated. Market development is not easy, and Mark shares his systematic process of commercializing a new therapy for a large and untapped indication. We also riff on what it takes to successfully raise money at all stages of a company’s journey. To learn more about CurvaFix, go to: https://curvafix.com/